IMRN - (Immuron Limited)

 IMRNのチャート


 IMRNの企業情報

symbol IMRN
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種   
概要 事業概要 --     
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear 2017年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/imrn
adr_tso 345878
EBITDA EBITDA ー
終値(lastsale) 8.183
時価総額(marketcap) 2830319.674
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 IMRNのテクニカル分析


 IMRNのニュース

   Immuron Shares Resume Trade Following Circuit Breaker To Upside; Stock Pulling Back From Session High, Still Up 30%  2020/11/11 11:42:00 Benzinga
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …
   70 Biggest Movers From Yesterday  2020/07/22 09:00:41 Benzinga Feeds
Gainers Midatech Pharma PLC-ADR (NASDAQ: MTP ) shares climbed 152.9% to close at $4.30 on Tuesday after the company announced a research collaboration for the Q-Sphera platform with a European pharmaceutical company. Owens & Minor, Inc. (NYSE: OMI ) rose 81.4% to close at $14.40 after the company announced preliminary results for the second quarter. Owens & Minor sees preliminary Q2 adjusted EPS of $0.18-$0.20. Novan, Inc. (NASDAQ: NOVN ) shares jumped 78.3% to close at $1.23 on Tuesday after climbing 12% on Monday. Immuron Limited (NASDAQ: IMRN ) shares gained 42.3% to close at $14.81 after the company said its IMM-124E — used to manufacture its flagship commercially available and over-the-counter gastrointestinal and digestive health immune supplements Travelan and Protectyn — has demonstrated neutralizing activity against the severe acute respiratory syndrome coronavirus-2, the virus that causes COVID-19. New Age Beverages Corporation (NASDAQ: NBEV ) climbed 41.4% to close at $2.46 after the company agreed to combine with ARIIX and 4 additional e-commerce/direct selling companies.
   Why Nanocap Biotech Immuron's Stock Is On A 2-Day Run  2020/07/21 14:57:08 Benzinga
Shares of Australian biopharma IMMURON LTD/S ADR (NASDAQ: IMRN ) were rallying for the second day in a row Tuesday following an announcement concerning a potential COVID-19 treatment option. Immuron's Coronavirus Development: Immuron's IMM-124E has demonstrated neutralizing activity against SARS-CoV-2, the virus that causes COVID-19, according to the company. The technology platform offers a potential new oral therapeutic approach to target SARS-CoV-2 in the gastrointestinal tract, Immuron said. IMM-124E is an oral polyclonal antibody therapy used to manufacture the biopharma's commercially available over-the-counter gastrointestinal and digestive heath immune supplements Travelan and Protectyn. It is also being evaluated in other indications such as NASH. The in-vitro assessment of the neutralization of … Full story available on Benzinga.com
   45 Stocks Moving in Tuesday's Pre-Market Session  2020/07/21 07:10:00 Benzinga
Gainers Immuron Limited (NASDAQ: IMRN) shares rose 97.9% to $20.60 in pre-market trading after the company reported neutralizing activity against …
   Mid-Day Market Update: Nasdaq Rises Over 1%; Immuron Shares Spike Higher  2020/07/20 12:00:00 Benzinga
Midway through trading Monday, the Dow traded down 0.28% to 26596.89 while the NASDAQ rose 1.1% to 10,618.66. The S&P also rose, gaining 0.23% to …
   70 Biggest Movers From Yesterday  2020/07/22 09:00:41 Benzinga Feeds
Gainers Midatech Pharma PLC-ADR (NASDAQ: MTP ) shares climbed 152.9% to close at $4.30 on Tuesday after the company announced a research collaboration for the Q-Sphera platform with a European pharmaceutical company. Owens & Minor, Inc. (NYSE: OMI ) rose 81.4% to close at $14.40 after the company announced preliminary results for the second quarter. Owens & Minor sees preliminary Q2 adjusted EPS of $0.18-$0.20. Novan, Inc. (NASDAQ: NOVN ) shares jumped 78.3% to close at $1.23 on Tuesday after climbing 12% on Monday. Immuron Limited (NASDAQ: IMRN ) shares gained 42.3% to close at $14.81 after the company said its IMM-124E — used to manufacture its flagship commercially available and over-the-counter gastrointestinal and digestive health immune supplements Travelan and Protectyn — has demonstrated neutralizing activity against the severe acute respiratory syndrome coronavirus-2, the virus that causes COVID-19. New Age Beverages Corporation (NASDAQ: NBEV ) climbed 41.4% to close at $2.46 after the company agreed to combine with ARIIX and 4 additional e-commerce/direct selling companies.
   Why Nanocap Biotech Immuron's Stock Is On A 2-Day Run  2020/07/21 14:57:08 Benzinga
Shares of Australian biopharma IMMURON LTD/S ADR (NASDAQ: IMRN ) were rallying for the second day in a row Tuesday following an announcement concerning a potential COVID-19 treatment option. Immuron's Coronavirus Development: Immuron's IMM-124E has demonstrated neutralizing activity against SARS-CoV-2, the virus that causes COVID-19, according to the company. The technology platform offers a potential new oral therapeutic approach to target SARS-CoV-2 in the gastrointestinal tract, Immuron said. IMM-124E is an oral polyclonal antibody therapy used to manufacture the biopharma's commercially available over-the-counter gastrointestinal and digestive heath immune supplements Travelan and Protectyn. It is also being evaluated in other indications such as NASH. The in-vitro assessment of the neutralization of … Full story available on Benzinga.com
   45 Stocks Moving in Tuesday's Pre-Market Session  2020/07/21 07:10:00 Benzinga
Gainers Immuron Limited (NASDAQ: IMRN) shares rose 97.9% to $20.60 in pre-market trading after the company reported neutralizing activity against …
   Mid-Day Market Update: Nasdaq Rises Over 1%; Immuron Shares Spike Higher  2020/07/20 12:00:00 Benzinga
Midway through trading Monday, the Dow traded down 0.28% to 26596.89 while the NASDAQ rose 1.1% to 10,618.66. The S&P also rose, gaining 0.23% to …
   Stock Alert: Immuron Shares Soar 76% In Early Trade  2020/07/20 09:04:00 RTT News
Shares of Immuron Ltd. (IMRN) are rallying over 76% in pre-market today, after the company announced that the Naval Medical Research Center or NMRC has received written guidance from the U.
   70 Biggest Movers From Yesterday  2020/07/22 09:00:41 Benzinga Feeds
Gainers Midatech Pharma PLC-ADR (NASDAQ: MTP ) shares climbed 152.9% to close at $4.30 on Tuesday after the company announced a research collaboration for the Q-Sphera platform with a European pharmaceutical company. Owens & Minor, Inc. (NYSE: OMI ) rose 81.4% to close at $14.40 after the company announced preliminary results for the second quarter. Owens & Minor sees preliminary Q2 adjusted EPS of $0.18-$0.20. Novan, Inc. (NASDAQ: NOVN ) shares jumped 78.3% to close at $1.23 on Tuesday after climbing 12% on Monday. Immuron Limited (NASDAQ: IMRN ) shares gained 42.3% to close at $14.81 after the company said its IMM-124E — used to manufacture its flagship commercially available and over-the-counter gastrointestinal and digestive health immune supplements Travelan and Protectyn — has demonstrated neutralizing activity against the severe acute respiratory syndrome coronavirus-2, the virus that causes COVID-19. New Age Beverages Corporation (NASDAQ: NBEV ) climbed 41.4% to close at $2.46 after the company agreed to combine with ARIIX and 4 additional e-commerce/direct selling companies.
   Why Nanocap Biotech Immuron's Stock Is On A 2-Day Run  2020/07/21 14:57:08 Benzinga
Shares of Australian biopharma IMMURON LTD/S ADR (NASDAQ: IMRN ) were rallying for the second day in a row Tuesday following an announcement concerning a potential COVID-19 treatment option. Immuron's Coronavirus Development: Immuron's IMM-124E has demonstrated neutralizing activity against SARS-CoV-2, the virus that causes COVID-19, according to the company. The technology platform offers a potential new oral therapeutic approach to target SARS-CoV-2 in the gastrointestinal tract, Immuron said. IMM-124E is an oral polyclonal antibody therapy used to manufacture the biopharma's commercially available over-the-counter gastrointestinal and digestive heath immune supplements Travelan and Protectyn. It is also being evaluated in other indications such as NASH. The in-vitro assessment of the neutralization of … Full story available on Benzinga.com
   45 Stocks Moving in Tuesday's Pre-Market Session  2020/07/21 07:10:00 Benzinga
Gainers Immuron Limited (NASDAQ: IMRN) shares rose 97.9% to $20.60 in pre-market trading after the company reported neutralizing activity against …
   Mid-Day Market Update: Nasdaq Rises Over 1%; Immuron Shares Spike Higher  2020/07/20 12:00:00 Benzinga
Midway through trading Monday, the Dow traded down 0.28% to 26596.89 while the NASDAQ rose 1.1% to 10,618.66. The S&P also rose, gaining 0.23% to …
   Stock Alert: Immuron Shares Soar 76% In Early Trade  2020/07/20 09:04:00 RTT News
Shares of Immuron Ltd. (IMRN) are rallying over 76% in pre-market today, after the company announced that the Naval Medical Research Center or NMRC has received written guidance from the U.

 関連キーワード  (― 米国株 IMRN Immuron Limited)

 twitter  (公式ツイッターやCEOツイッターなど)